Comparison of structure and organization of cutaneous lipids in a reconstructed skin model and human skin: Spectroscopic imaging and chromatographic profiling

Experimental Dermatology

Volumn 23, Issue 6, 2014, Pages 441-443

  Tfayli, Ali ^a   Bonnier, Franck ^b   Farhane, Zeineb ^a   Libong, Danielle ^a   Byrne, Hugh J ^b   Baillet Guffroy, Arlette ^a  

^a University Paris Saclay   (France)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Artificial skin models; High performance liquid chromatography; Human skin; Lipids; Raman spectroscopy; Stratum corneum

Indexed keywords

CERAMIDE; CHOLESTEROL; FATTY ACID; KERATIN; SKIN LIPID; LIPID;

ARTICLE; ARTIFICIAL SKIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; PROTEIN SECONDARY STRUCTURE; RAMAN SPECTROMETRY; RECONSTRUCTED SKIN MODEL; SKIN; SKIN PERMEABILITY; SKIN SURFACE; STRATUM CORNEUM; ADULT; BIOLOGICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; FEMALE; MIDDLE AGED;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; LIPIDS; MIDDLE AGED; MODELS, BIOLOGICAL; SKIN; SKIN, ARTIFICIAL; SPECTRUM ANALYSIS, RAMAN;

EID: 84901491126     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12423     Document Type: Article

References (30)

1. Barbotteau Y, Gontier E, Barberet P et al. Nucl Instrum Methods Phys Res, Sect B 2005: 231: 286-291.
2. Netzlaff F, Lehr C M, Wertz P W et al. Eur J Pharm Biopharm 2005: 60: 167-178.
3. EU, COM (2013) 135 final, Communication from the commission to the European Parliament and the council in, vol. 135 2013.
4. Ajani G, Sato N, Mack J A et al. Exp Cell Res 2007: 313: 3005-3015.
5. Brohem C A, Cardeal L B, Tiago M et al. Pigment Cell Melanoma Res 2010: 24: 35-50.
6. Boyce S T, Warden G D. Am J Surg 2002: 183: 445-456.
7. El Ghalbzouri A, Siamari R, Willemze R et al. Toxicol In Vitro 2008: 22: 1311-1320.
8. Ponec M, Boelsma E, Weerheim A et al. Int J Pharm 2000: 203: 211-225.
9. Ponec M. Adv Drug Deliv Rev 2002: 54(Suppl 1): S19-S30.
10. Ponec M, Boelsma E, Gibbs S et al. Skin Pharmacol Appl Skin Physiol 2002: 15(Suppl 1): 4-17.
11. Kojima H, Katoh M, Shinoda S et al. J Appl Toxicol 2013: doi: 10.1002/jat.2937. [Epub ahead of print]
12. Alepee N, Grandidier M H, Cotovio J. Toxicol In Vitro 2014: 28: 131-145.
13. Boelsma E, Gibbs S, Faller C et al. Acta Derm Venereol 2000: 80: 82-88.
14. Elbayed K, Berl V, Debeuckelaere C et al. Chem Res Toxicol, 2013: 26: 136-145.
15. Garcia N, Doucet O, Bayer M et al. Int J Cosmet Sci 2002: 24: 25-34.
16. Tfayli A, Piot O, Draux F et al. Biopolymers 2007: 87: 261-274.
17. Netzlaff F, Kaca M, Bock U et al. Eur J Pharm Biopharm 2007: 66: 127-134.
18. Lotte C, Patouillet C, Zanini M et al. Skin Pharmacol Appl Skin Physiol 2002: 15(Suppl 1): 18-30.
19. Schreiber S, Mahmoud A, Vuia A et al. Toxicol In Vitro 2005: 19: 813-822.
20. Kuchler S, Struver K, Friess W. Expert Opin Drug Metab Toxicol 2013: 9: 1255-1263.
21. Rozman B, Gasperlin M, Tinois-Tessoneaud E et al. Eur J Pharm Biopharm 2009: 72: 69-75.
22. Vyumvuhore R, Tfayli A, Duplan H et al. J Raman Spectrosc 2013: 44: 1077-1083.
23. Plasencia I, Norlen L, Bagatolli L A. Biophys J 2007: 93: 3142-3155.
24. Mack Correa M C, Mao G, Saad P et al. Exp Dermatol 2014: 23: 39-44.
25. Marcott C, Lo M, Kjoller K et al. Exp Dermatol 2013: 22: 419-421.
26. Tfayli A, Jamal D, Vyumvuhore R et al. Analyst 2013: 138: 6582-6588.
27. Guillard E, Tfayli A, Manfait M et al. Anal Bioanal Chem 2011: 399: 1201-1213.
28. Tfayli A, Guillard E, Manfait M et al. Anal Bioanal Chem 2010: 397: 1281-1296.
29. Tfayli A, Guillard E, Manfait M et al. Analyst 2012: 137: 5002-5010.
30. Tfayli A, Guillard E, Manfait M et al. Eur J Dermatol 2012: 22: 36-41.